Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - OPERATING INCOME
Operating Income CRVS - Corvus Pharmaceuticals, Inc.
-23.4 M
LAST VALUE
22.16%
2 YEAR CAGR
13.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR